Qunying Mao

发表

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

Xing Wu, Zhenglun Liang, Dongming Liu, 2023, Signal transduction and targeted therapy.

A Short 5′triphosphate RNA nCoV-L Induces a Broad-Spectrum Antiviral Response by Activating RIG-I

Xing Wu, Zhenglun Liang, Xiuling Li, 2022, Viruses.

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays

Xing Wu, Zhenglun Liang, Q. Mao, 2023, Expert review of vaccines.

Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data

Xing Wu, W. Kong, Zhenglun Liang, 2015, Human vaccines & immunotherapeutics.

Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies

Jialu Zhang, Zhenglun Liang, Fan Gao, 2021, Expert review of vaccines.

Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches

Xing Wu, W. Kong, Shixia Wang, 2015, PloS one.

Research progress on circular RNA vaccines

Zhenglun Liang, Dongming Liu, Q. Mao, 2023, Frontiers in Immunology.

Molecular Determinants of Enterovirus 71 Viral Entry

Wenhui Li, Zhenglun Liang, Xinliang Shen, 2012, The Journal of Biological Chemistry.

An inactivated enterovirus 71 vaccine in healthy children.

Jiansheng Liu, Hongling Zhao, Junzhi Wang, 2014, The New England journal of medicine.

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3

Xing Wu, Wenhui Li, Zhenglun Liang, 2016, Journal of Virological Methods.

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy

Zhenglun Liang, Jianyang Liu, Yu Bai, 2023, Frontiers in immunology.

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.

Wenbo Xu, Nan Wang, Zhenglun Liang, 2014, The New England journal of medicine.

Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates

Xing Wu, Xiaozhong Peng, Changgui Li, 2022, Signal Transduction and Targeted Therapy.

Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNA

W. Kong, Zhenglun Liang, Pan Chen, 2016, PloS one.

The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children

N. Xia, T. Cheng, Junzhi Wang, 2013, PloS one.

Progress on the research and development of inactivated EV71 whole-virus vaccines

Junzhi Wang, Zhenglun Liang, Jing-xin Li, 2013, Human vaccines & immunotherapeutics.

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.

Junzhi Wang, Zhenglun Liang, F. Li, 2011, Vaccine.

Reactogenicity and Immunogenicity of an Enterovirus 71 Vaccine in Chinese Healthy Children and Infants

K. Chu, Jing-xin Li, F. Zhu, 2012, The Pediatric infectious disease journal.

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Jialu Zhang, Changgui Li, Junzhi Wang, 2021, Emerging microbes & infections.

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine

Changgui Li, Zhenglun Liang, K. Xu, 2022, Vaccine.

Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism

Zhenglun Liang, Fan Gao, Lian-lian Bian, 2022, Emerging microbes & infections.

A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis

Zhenglun Liang, Yao Su, Fan Gao, 2019, Antiviral research.

Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo

Xing Wu, Zhenglun Liang, Xiuling Li, 2018, Human vaccines & immunotherapeutics.

Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine

Hongling Zhao, Zhenglun Liang, Ying Zhang, 2013, PloS one.

A cross-sectional seroepidemiology study of EV-D68 in China

Xing Wu, Zhenglun Liang, F. Zhu, 2018, Emerging Microbes & Infections.

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines

Xing Wu, Zhenglun Liang, Zhongfang Wang, 2022, Frontiers in Immunology.

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern

Xing Wu, Zhenglun Liang, Fan Gao, 2022, Human vaccines & immunotherapeutics.

Impact of the Delta variant on vaccine efficacy and response strategies

Xing Wu, Zhenglun Liang, Fan Gao, 2021, Expert review of vaccines.

Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012‐2013

Zhenglun Liang, Jing-xin Li, F. Zhu, 2015, Journal of medical virology.

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Pei Liu, Fan Gao, Kai Chu, 2013, The Lancet.

How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review

Xing Wu, Zhenglun Liang, Fan Gao, 2022, Expert review of anti-infective therapy.

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV

Zhenglun Liang, Dongming Liu, Miao Xu, 2022, Emerging microbes & infections.

Enterovirus 71 viral capsid protein linear epitopes: Identification and characterization

Junzhi Wang, Zhenglun Liang, F. Zhu, 2012, Virology Journal.

The next major emergent infectious disease: reflections on vaccine emergency development strategies

Xing Wu, Zhenglun Liang, Zhongfan Wang, 2022, Expert review of vaccines.

Coxsackievirus A16

Zhenglun Liang, Lian-lian Bian, Q. Mao, 2014, Human vaccines & immunotherapeutics.

Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials

Zhenglun Liang, Jing-xin Li, F. Zhu, 2014, Expert review of vaccines.

A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation

Junzhi Wang, Zhenglun Liang, P. Mao, 2012, Journal of Virology.

A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model

Zhenglun Liang, Qian He, Qunying Mao, 2024, Viruses.

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases

Zhenglun Liang, Lian-lian Bian, Q. Mao, 2016, Emerging Microbes & Infections.

Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems

Zhenglun Liang, Fan Gao, Lian-lian Bian, 2019, Expert review of anti-infective therapy.

Effect of freezing on recombinant hepatitis E vaccine

Xing Wu, Zhenglun Liang, Fan Gao, 2019, Human vaccines & immunotherapeutics.

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial

F. Zhu, Xiuling Li, Pei Liu, 2022, Human vaccines & immunotherapeutics.

EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)

Zhenglun Liang, Lian-lian Bian, Q. Mao, 2016, Expert review of vaccines.

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study

K. Chu, Zhenglun Liang, Jing-xin Li, 2017, The Journal of infectious diseases.

Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.

Ziyan Wang, Chao Zhang, Xinxing Ma, 2021, Vaccine.

A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.

N. Xia, T. Cheng, Zhenglun Liang, 2016, Antiviral research.

Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide

Zhenglun Liang, Lian-lian Bian, Q. Mao, 2015, Expert review of anti-infective therapy.